Association of Two Polymorphisms in the Peroxisome Proliferator-Acativated Receptor-γ Gene With Adenomyosis, Endometriosis, and Leiomyomata in Japanese Women

Miyo Kiyomizu, Jo Kitawaki, Hiroshi Obayashi, Mitsuhiro Ohta, Hisato Koshiba, Hiroaki Ishihara, Hideo Honjo
Journal of the Society for Gynecologic Investigation · 2006 · vol. 13(5) , pp. 372–377 · doi:10.1016/j.jsgi.2006.03.005 · PMID:16725353 · W2073481259
article OA: closed CC0 ⤵ 15 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the association between two genetic variations in the PPARγ gene and the prevalence of adenomyosis, endometriosis, and leiomyomata in Japanese women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosisadenomyosis

MeSH descriptors

Endometriosis Leiomyoma Polymorphism, Genetic PPAR gamma Uterine Neoplasms DNA DNA Endometriosis Female Gene Frequency Genotype Humans Japan Leiomyoma PPAR gamma Uterine Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (31)

Cited by (15)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:18.313808+00:00
License: CC0 · commercial use OK